Quick Facts

• Therapeutic Domain: Dry eye syndrome
• Primary Benefit: May help to relieve the symptoms of ocular dryness
• Mode of Action: Provides lubrication and moisture to the eye surface

Siccafluid 0.25% is an ophthalmic preparation designed for the symptomatic management of dry eye conditions. This medication is indicated to help relieve the sensations associated with inadequate natural tear production, which can include dryness, burning, grittiness, and irritation. By functioning as a tear substitute, it supports the stability of the tear film on the eye's surface.

Its main purpose is to provide a lubricating and moistening layer to the eye, thereby assisting in the protection of the corneal and conjunctival surfaces from drying out. Using this product may potentially improve overall eye comfort for individuals experiencing chronic ocular dryness, known medically as keratoconjunctivitis sicca. This class of product serves a role in supporting ocular hydration.

This option is used to address the discomfort resulting from reduced tear volume or quality.

Who Can and Cannot Use Siccafluid 0.25%?

This section defines the populations officially documented as eligible or non-eligible for use of Siccafluid 0.25% (Carbomer Ophthalmic Gel), based on regulatory documentation.

Contraindicated and Restricted Populations

The primary non-eligibility rule is the absolute contraindication for individuals with a known hypersensitivity (allergy) to the active substance, Carbomer, or to any of the excipients in the gel formulation. Use is strictly prohibited for these patients.

Eligibility Conditions

The medicine is generally permitted for use by adults and older adults with dry eye conditions. For women who are pregnant or breastfeeding, the product is not recommended unless specifically advised by a healthcare professional, due to the regulatory classification of insufficient human safety data.

Additionally, patients who wear soft contact lenses must adhere to the labeled condition of removing the lenses prior to application and waiting before reinsertion, due to the presence of preservatives.

Interactions with other medicines and products

Interaction Scope

Authoritative regulatory documents define the interaction profile of Siccafluid 0.25% primarily through procedural constraints concerning its co-administration with other ophthalmic preparations. The high viscosity of the product, which is necessary for its intended effect, requires a specific order and timing when other eye drops or eye ointments are being used concurrently.

Interacting Product Category:

Mechanistic Basis:

• Physical Interference/Dilution: Concurrent use, without proper spacing, may dilute the product or cause it to be prematurely cleared from the eye, potentially reducing the effectiveness of both medicines.

Procedural and Timing Constraints

When co-administering Siccafluid 0.25% with any other topical eye medication, strict adherence to the prescribed order and time interval is required to ensure that each product acts as intended. This is classified as a use-with-caution scenario requiring careful management of application timing.

These constraints establish the product's official interaction structure, defining how other medicines can be safely and effectively incorporated into the patient's regimen without compromising the clinical performance of the eye gel.

Carbomer 0.25%, the active component in Siccafluid, functions primarily as a high molecular weight hydrophilic polymer. Following topical administration to the ocular surface, the carbomer chains engage in non-covalent interactions with the intrinsic mucin layer of the corneal and conjunctival epithelium. This interaction establishes a mucoadhesive bond, which is a key determinant of its retention profile. The local pH conditions cause the polymer to swell and uncoil, dramatically increasing the formulation’s viscosity. This physicochemical transformation generates a viscoelastic hydrogel film that spreads across the epithelial surface. This film acts as a transient supplement to the natural tear film. By creating a stabilizing layer over the surface, the presence of the polymer layer increases the pre-corneal tear film break-up time. Mechanistically, this action corresponds to an extension of the retention time of the applied formulation within the ocular cul-de-sac. This extended retention is a direct consequence of its biophysical interaction with the epithelium.

Application Method

Siccafluid 0.25% is an ophthalmic gel intended for administration into the eye. Before applying the gel, it is necessary to wash your hands thoroughly. To apply the product, the head should be tilted slightly back while looking upward. The lower eyelid is gently pulled down with one hand to create a small pocket between the eyelid and the eye.

The container should be held vertically above the eye, ensuring the tip does not touch the eye, eyelids, or any other surfaces to maintain the sterility of the gel. A single drop is then instilled into the space created by the lower eyelid. After application, the eye should be closed for a short period, and the finger can be used to apply gentle pressure to the inner corner of the eye (near the nose) to help the gel remain in place.

Usage with Contact Lenses

If you wear contact lenses, they must be removed before using Siccafluid 0.25%. Once the gel has been applied, a waiting period is required before the lenses can be reinserted. This allows the gel to distribute evenly across the surface of the eye and prevents potential interactions with the lens material.

Sequential Use with Other Eye Medications

When multiple ophthalmic products are being used, a specific interval must be maintained between the administration of each medication. If you are using other eye drops or ointments in addition to Siccafluid 0.25%, wait several minutes between the applications. In these instances, Siccafluid 0.25% should generally be the last product administered, as its gel consistency helps it remain on the eye surface for an extended duration.

Research evidence / Overview of studies for Siccafluid 0.25% (Carbomer 974P)

Dry Eye Syndrome

Studies have investigated the use of Siccafluid 0.25%, which contains the lubricating ingredient Carbomer 974P, in studies exploring its use as a substitute for natural tears for individuals with dry eye syndrome. This is a common condition where eyes do not produce enough tears or when the quality of tears is poor, leading to symptoms like irritation, burning, and the feeling of having something gritty or sandy in the eye.

Research has included studies that followed groups of patients with dry eyes over several months. For example, one study tracked patients for six months to see whether the eye gel might be associated with changes in their reported symptoms and certain measurements of the eye's surface and tear film. The main purpose was to examine the association between using this product and changes in comfort and measurements of the eye's front surface.

Findings from some of these studies indicated an association with a lower reported frequency of ocular dryness and other dry eye symptoms. Additionally, research noted that use of the gel was associated with changes in the tear film break-up time (a measure of how long the tears stay stable on the eye's surface before drying out). One study specifically noted that patients who had a shorter tear break-up time before treatment experienced a reported change in their overall dry eye symptom scores after using the gel for six months. These results were interpreted as a potential association with changes in the stability of the tear film.

Evidence Differences in Special Populations

Some studies have explored whether the effects of Siccafluid 0.25% might be different for patients with Sjögren's syndrome, a condition where dry eye is a major symptom, compared to those with dry eye from other causes (referred to as non-Sjögren’s dry eye).

A six-month study suggested that patients in both the Sjögren’s syndrome group and the non-Sjögren’s dry eye group reported improvements in their symptoms of dryness. Both groups indicated an association with reported changes in the frequency and intensity of dryness and in the tear film break-up time. This suggested that the observed changes in symptoms were not substantially different between the Sjögren’s syndrome group and the non-Sjögren’s dry eye group.

Gaps and Limitations in Research

Existing research has explored the effects of this type of Carbomer eye gel on dry eye symptoms and tear film stability. However, there are areas where more information would be helpful. Research often compares the product to the patient's condition before treatment or to no treatment at all, but there is generally a lack of published, large-scale studies directly comparing Siccafluid 0.25% to many of the other lubricating products available today. This means it can be difficult to draw firm conclusions about how its effects might compare to other tear substitutes. Furthermore, while short-term studies are common, more research that follows patients for very long periods would help to better understand the long-term patterns of use.

Key Studies & References

1. [Efficacy of Carbopol 974P (Siccafluid) in the treatment of severe to moderate keratoconjunctivitis sicca in patients with primary Sjögren's syndrome not responding to standard treatment with artificial tears]
2. Liquivisc 0.25% Eye Gel (Carbomer 974P) Product Information

Common questions about Siccafluid 0.25% (FAQ)

Q: What is Siccafluid 0.25% used for?

Siccafluid 0.25% is indicated for use as a tear substitute to relieve the symptoms of dry eyes. It is intended to help lubricate and moisten the eye's surface, providing relief from discomfort.

Q: How long should I use Siccafluid 0.25%?

The duration of use should be discussed with a healthcare professional. It is generally used as needed or as recommended by your doctor to manage persistent dry eye symptoms. Continued long-term use should be reviewed regularly by your eye specialist.

Q: Can Siccafluid 0.25% be used with contact lenses?

It is generally recommended to remove contact lenses before applying Siccafluid 0.25%. Lenses should typically be reinserted at least 15 minutes after application to allow the product time to spread across the eye's surface. Always check the specific product information leaflet for precise guidance on contact lens use.

How to Store and Dispose of Siccafluid 0.25%

Official regulatory documents define specific requirements for the storage, handling, and disposal of Siccafluid 0.25% to maintain its stability and ensure safety.

Storage and Stability Requirements

Disposal Guidance

To safely dispose of this product, any unused medicine or waste material must be returned to a pharmacist. Disposal through household waste or wastewater is not permitted by official guidance, which is designed to protect the environment.